Plasma total homocysteine and hospitalizations for cardiovascular disease: The Hordaland Homocysteine Study

Archives of Internal Medicine

Volumn 162, Issue 12, 2002, Pages 1374-1381

  Nurk, Eha ^a   Tell, Grethe S ^a   Vollset, Stein Emil ^a   Nygård, Ottar ^a   Refsum, Helga ^a   Ueland, Per M ^a  

^a UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

HOMOCYSTEINE;

ADULT; AGED; AGING; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; FEMALE; HEART MUSCLE REVASCULARIZATION; HOSPITALIZATION; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; NORWAY; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; RISK FACTOR;

EID: 0037166647     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.162.12.1374     Document Type: Article

References (43)

1. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: Probable benefits of increasing folic acid intakes
2. Homocyst(e)ine and cardiovascular disease: A critical review of the epidemiologic evidence
3. Homocysteine and cardiovascular disease
4. Blood levels of homocysteine and increased risks of cardiovascular disease: Causal or casual?
5. Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study
6. Hyperhomocysteinemia and venous thrombosis: A meta-analysis
7. Homocyst(e)ine and risk of cardiovascular disease in the multiple risk factor intervention trial
8. Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: The Atherosclerosis Risk in Communities (ARIC) Study
9. Plasma total homocysteine and risk of angina pectoris with subsequent coronary artery bypass surgery
10. Plasma homocysteine levels and mortality in patients with coronary artery disease
11. Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women
12. Nonfasting plasma total homocysteine level and mortality in middle-aged and elderly men and women in Jerusalem
13. The controversy over homocysteine and cardiovascular risk
14. Total homocysteine and cardiovascular disease
15. Serum homocysteine and risk of coronary heart disease and cerebrovascular disease in elderly men: A 10-year follow-up
16. 5 and risk of myocardial infarction in US physicians
17. Total plasma homocysteine and cardiovascular risk profile: The Hordaland Homocysteine Study
18. Homocysteine and other thiols in plasma and urine: Automated determination and sample stability
19. Fully automated fluorescence assay for determining total homocysteine in plasma
20. Plasma total homocysteine and cardiovascular and noncardiovascular mortality: The Hordaland Homocysteine Study
21. Homocysteine and major coronary events: A prospective population study amongst women
22. Plasma homocysteine as a risk factor for vascular disease: The European Concerted Action Project
23. Prospective study of serum total homocysteine concentration and risk of stroke in middleaged British men
24. Short-term and long-term variability of plasma homocysteine measurement
25. Within-person variation of plasma homocysteine and effects of posture and tourniquet application
26. Day-to-day, postprandial, and orthostatic variation of total plasma homocysteine
27. Plasma homocysteine is not subject to seasonal variation
28. Variability and determinants of total homocysteine concentrations in plasma in an elderly population
29. Significance of various parameters derived from biological variability of lipoprotein(a), homocysteine, cysteine, and total antioxidant status
30. Myocardial infarction in young patients
31. Hyperhomocysteinaemia and progression of coronary atherosclerosis
32. Influence of nonlipid and lipid risk factors on coronary artery disease progression
33. Hyperhomocysteinemia, atherosclerosis and thrombosis
34. Thrombosis in the young: Effect of atherosclerotic risk factors on the risk of myocardial infarction associated with prothrombotic factors
35. Thrombosis in the young: Epidemiology and risk factors: A focus on venous thrombosis
36. Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulindependent diabetes mellitus: A population-based study
37. Hyperhomocysteinemia increases risk of death, especially in type 2 diabetes: 5-Year follow-up of the Hoorn study
38. Plasma homocysteine and all-cause mortality in diabetes
39. Homocysteine and atherothrombosis mechanisms for injury
40. Acute hyperhomocysteinaemia and endothelial dysfunction
41. Homocysteine as atherothrombotic agent: Is the bark worse than the bite?
42. Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (≥40 μmol/liter): The Hordaland Homocysteine Study
43. Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies